GLP-1RAs
2 stories
-
healthGLP-1RAs Linked to Lower Death Risk in Brain Cancer, Diabetes Patients
A 2026 study finds GLP-1 receptor agonists reduce death risk by 37% in patients with brain metastases and Type 2 diabetes, highlighting potential neuroprotective benefits.
-
healthGLP-1 RAs Show No Link to Thyroid Cancer Recurrence
New research indicates GLP-1 receptor agonists do not increase recurrence or progression risk in differentiated thyroid cancer patients.